ALBUMEDIX LTD has a total of 49 patent applications. It increased the IP activity by 160.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are KSQ THERAPEUTICS INC, GUANGZHOU ZHAOTAI INVIVO BIOMEDICINE CO LTD and CELLECTIS SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | Australia | 8 | |
#3 | EPO (European Patent Office) | 8 | |
#4 | Israel | 5 | |
#5 | Canada | 3 | |
#6 | Brazil | 2 | |
#7 | Japan | 2 | |
#8 | Republic of Korea | 2 | |
#9 | China | 1 | |
#10 | Hong Kong | 1 | |
#11 | Mexico | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Basic materials chemistry | |
#5 | Measurement | |
#6 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Enzymes | |
#6 | Fermentation | |
#7 | Preservation of human bodies | |
#8 | Microorganisms | |
#9 | Analysing materials | |
#10 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Cameron Jason | 13 |
#2 | Finnis Christopher John Arthur | 12 |
#3 | Sleep Darrell | 11 |
#4 | Andersen Jan Terje | 11 |
#5 | Delahay Karen Ann | 9 |
#6 | Plumridge Andrew | 8 |
#7 | Mclaughlan Jennifer Mary | 8 |
#8 | Sandlie Inger | 8 |
#9 | Nordeide Per Kristoffer | 8 |
#10 | Friis Esben Peter | 7 |
Publication | Filing date | Title |
---|---|---|
WO2018234349A1 | Improved protein expression strains | |
EP3429345A1 | Uses of recombinant yeast-derived serum albumin | |
CA3005953A1 | Improved protein expression strains | |
AU2016308504A1 | Albumin variants and conjugates | |
IL229936A | Albumin formulation and use | |
AU2012251583A1 | Albumin variants | |
MX367177B | Albumin variants. |